Saturday 17 October 2026
Export CHRS’s income statement to Excel — free account
Coherus Oncology, Inc.
CHRS Healthcare Biotechnology
In the quarter to June 2026, revenue grew 39.5%, EPS fell 105.1%, free cash flow fell 33.2% and total debt rose 1.03%, each against the same quarter a year earlier.
1.00
0.07
−6.54%
Follow CHRS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 6 | 5 | 3 |
| (155,671.52%) | (473.47%) | (355.31%) | (146.27%) | ||
| 30.34% | 47.54% | 58.47% | (41.90%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
171.64% | 248.32% | 249.03% | (223.41%) | |
Average Days of Receivables |
2,460.67 | 159.41 | 175.25 | 102.13 | |
Free Cash Flow per Share |
(0.78) | (1.18) | (1.25) | (1.20) | |
Free Cash Flow |
(90.19) | (138.51) | (170.57) | (186.03) | |
| Other line items | |||||
Cash ROIC |
(28.51%) | (51.27%) | (60.31%) | (91.46%) | |
Accounts Receivable Turnover |
0.17 | 0.60 | 1.10 | 0.76 | |
Accounts Payable Turnover |
0.54 | 0.72 | 0.57 | 0.62 | |
Inventory Turnover |
0.50 | 3.74 | 3.59 | 3.11 | |
Average Days of Payables |
725.77 | 261.98 | 279.79 | 303.77 | |
Days of Inventory on Hand |
59.71 | 83.81 | 117.60 | 130.73 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
265.56% | 258.20% | 226.25% | 198.70% | |
Selling, General and Administrative Expense of Revenue |
286.90% | 238.56% | 208.35% | 181.79% | |
Share Based Compensation of Revenue |
55.35% | 40.23% | 29.82% | 21.87% | |
Interest Coverage |
(24.15) | (20.12) | (19.02) | (17.47) | |
Operating CF/Net income |
(0.58) | (0.82) | (0.92) | 1.41 | |
Depreciation/Fixed assets |
2.49 | 2.92 | 3.44 | 4.17 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.32 | 0.36 | 0.34 | 0.33 | |
Operating CF per Share |
(0.78) | (1.18) | (1.25) | (1.20) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates